Press Room

Digital RDD 2020

Start
Sunday, April 26, 2020 - 00:00
End
Tuesday, June 30, 2020 - 00:00
Location: online

RDD 2020 and IPAC-RS in Desert Springs, California, April 26-May 1, 2020 are canceled. The organization is holding the Digital RDD 2020.

 

Digital RDD 2020 is open 24/7 until June 30

 

HOVIONE DIGITAL PRESENTATION:

  • Title: “Spray Dried Particles for Inhalation: Process Development Following a QbD Approach”
    João Henriques, PhD, Hovione, Lisbon, Portugal

 

HOVIONE DIGITAL POSTER:

  • Title: “Spray-dried Microparticles vs. Chimeral Agglomerates for Nasal Powder Delivery: Characterization and Aerodynamic Performance"
    Patricia Henriques, PhD Student, R&D DPD, Hovione, Lisbon, Portugal

 

 

If you would like to find more about Hovione's full range of inhalation development servicesparticle engineering and development by design schedule a meeting with us.

Schedule a meeting button | Hovione

Our colleague Steve Landelius will be pleased to meet you.

steve-landelius-photo

Steven Landelius

Business Development Manager
 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025